SO
STRS Ohio Portfolio holdings
AUM
$26.8B
1-Year Return
24.25%
This Quarter Return
+13.11%
1 Year Return
+24.25%
3 Year Return
+105.97%
5 Year Return
+185.64%
10 Year Return
+428.63%
AUM
$25.1B
AUM Growth
+$1.07B
(+4.5%)
Cap. Flow
-$1.36B
Cap. Flow
% of AUM
-5.41%
Top 10 Holdings %
Top 10 Hldgs %
26.72%
Holding
2,074
New
166
Increased
456
Reduced
1,182
Closed
160
Top Buys
| 1 |
Welltower
WELL
|
$43.3M |
| 2 |
KKR & Co
KKR
|
$41.1M |
| 3 |
Flutter Entertainment
FLUT
|
$40.1M |
| 4 |
Imperial Oil
IMO
|
$35.4M |
| 5 |
DexCom
DXCM
|
$33.6M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$92.2M |
| 2 |
Broadcom
AVGO
|
$65.2M |
| 3 |
Microsoft
MSFT
|
$57.5M |
| 4 |
Meta Platforms (Facebook)
META
|
$55.2M |
| 5 |
Golub Capital BDC
GBDC
|
$52.4M |
Sector Composition
| 1 | Technology | 27.3% |
| 2 | Financials | 13.2% |
| 3 | Healthcare | 11.91% |
| 4 | Consumer Discretionary | 10.02% |
| 5 | Industrials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Vishay Intertechnology
VSH
$2.11B
| $61K | ﹤0.01% |
2,700
-17,900
| -87% | -$404K |
|
1752
Walker & Dunlop
WD
$2.98B
| $60K | ﹤0.01% |
600
-900
| -60% | -$90K |
|
1753
Larimar Therapeutics
LRMR
$337M
| $59K | ﹤0.01% |
7,900
+2,600
| +49% | +$19.4K |
|
1754
SelectQuote
SLQT
$358M
| $59K | ﹤0.01% |
29,800
-1,900
| -6% | -$3.76K |
|
1755
Sanara MedTech
SMTI
$299M
| $59K | ﹤0.01% |
1,600
-100
| -6% | -$3.69K |
|
1756
Simulations Plus
SLP
$279M
| $57K | ﹤0.01% |
1,400
-4,000
| -74% | -$163K |
|
1757
International Bancshares
IBOC
$4.45B
| $56K | ﹤0.01% |
1,000
-300
| -23% | -$16.8K |
|
1758
Ribbon Communications
RBBN
$707M
| $56K | ﹤0.01% |
+17,600
| New | +$56K |
|
1759
OFG Bancorp
OFG
$1.99B
| $55K | ﹤0.01% |
1,500
-100
| -6% | -$3.67K |
|
|
PSTL
1760
Postal Realty Trust
PSTL
$393M
| $54K | ﹤0.01% |
3,800
-200
| -5% | -$2.84K |
|
1761
Protagonist Therapeutics
PTGX
$3.77B
| $54K | ﹤0.01% |
1,900
-500
| -21% | -$14.2K |
|
1762
PepGen
PEPG
$45.9M
| $52K | ﹤0.01% |
3,600
+1,700
| +89% | +$24.6K |
|
|
TEAD
1763
Teads Holding Co. Common Stock
TEAD
$155M
| $51K | ﹤0.01% |
13,000
+3,400
| +35% | +$13.3K |
|
1764
Stride
LRN
$7.01B
| $50K | ﹤0.01% |
800
| – | – |
|
|
REFI
1765
Chicago Atlantic Real Estate Finance
REFI
$303M
| $50K | ﹤0.01% |
3,200
-200
| -6% | -$3.13K |
|
1766
Beam Therapeutics
BEAM
$2.11B
| $49K | ﹤0.01% |
+1,500
| New | +$49K |
|
|
SHYF
1767
DELISTED
The Shyft Group
SHYF
| $49K | ﹤0.01% |
4,000
-5,100
| -56% | -$62.5K |
|
1768
CoreCard
CCRD
$212M
| $48K | ﹤0.01% |
4,400
+3,400
| +340% | +$37.1K |
|
1769
Sensient Technologies
SXT
$4.79B
| $48K | ﹤0.01% |
700
| – | – |
|
1770
Nuvectis Pharma
NVCT
$170M
| $47K | ﹤0.01% |
5,800
-400
| -6% | -$3.24K |
|
1771
P3 Health Partners
PIII
$28.7M
| $47K | ﹤0.01% |
930
-58
| -6% | -$2.93K |
|
1772
Amylyx Pharmaceuticals
AMLX
$910M
| $46K | ﹤0.01% |
16,500
-1,000
| -6% | -$2.79K |
|
1773
Rocket Pharmaceuticals
RCKT
$354M
| $45K | ﹤0.01% |
+1,700
| New | +$45K |
|
|
EGRX
1774
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $45K | ﹤0.01% |
8,700
-500
| -5% | -$2.59K |
|
1775
Altimmune
ALT
$334M
| $43K | ﹤0.01% |
+4,300
| New | +$43K |
|